About the Journals

About CLC

Tumor-specific, Peer-reviewed, Indexed in PubMed

1. Clinical Lung Cancer is a tumor-specific, peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer.
2. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer.
3. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

About the Editor

David R. Gandara
Professor of Medicine
University of California Davis Cancer Center

Dr Gandara is a member of the Board of Directors of the International Association for the Study of Lung Cancer and the Addario Foundation. He served as a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) and as secretary-treasurer. Dr Gandara is also a member of many professional committees, including the NCI Investigational Drug Steering Committee and the NCI Science Correlates Committee. He currently is the Chair of the Southwest Oncology Group’s Lung Committee (SWOG). In addition, Dr Gandara is also an accomplished author who has published more than 225 articles, written 10 book chapters, and authored more than 255 abstracts and 125 presentations.

Dr Gandara holds a B.A. from the University of Texas and an M.D. with honors from the University of Texas Medical Branch in Galveston, TX.

How to Submit

Clinical Lung Cancer focuses on original articles describing various aspects of clinical and translational research of lung cancer.

1. Download Instructions

Download instructions, submission policies, and related information

2. Submit Your Paper Online

Submit Your Paper (First-time users must register)

Questions?

Contact David Allen for questions on the manuscript submission process.

Clinical Lung Cancer Editorial Office:
CIG Media Group, LP
3500 Maple Ave., Ste. 700
Dallas, TX 75219
Phone: (214)367-3333
Fax: (214) 367-3301